The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwNHL 2017 | iwNHL 2017: The future of lymphoma research and treatment
In this panel the future of lymphoma research and treatment, as well as highlights of the 2017 International Workshop in Non-Hodgkin Lymphoma (iwNHL) in Vancouver, BC, Canada, are discussed by John Gribben, MD, DSc, FRCPath, FMed Sci from Barts Cancer Institute, London, UK, Laurie Sehn, MD from the BC Cancer Agency, Vancouver, Canada, Owen O’Connor, MD, PhD from Columbia University Medical Center, New York, NY and Catherine Bollard, MBChB, MD, FRACP, FRCPA from the Children’s National Health System and The George Washington University, Washington, DC. Topics highlighted include novel agents and combinations, the mutational landscape of lymphoma and the role of immuno-oncology. The future of lymphoma research and clinical management is also debated, touching upon the design of clinical trials and bioinformatics approaches. This video was supported by Janssen Pharmaceuticals (a Johnson & Johnson Company) through an unrestricted educational grant to Magdalen Medical Publishing. The company had no influence on the production of this content.
